TransMedics Group Inc. (NASDAQ: TMDX) started the day on July 23, 2021, with a price decrease of -1.23% at $29.60. During the day, the stock rose to $30.1563 and sunk to $28.87 before settling in for the price of $29.97 at the close. Taking a more long-term approach, TMDX posted a 52-week range of $11.51-$49.50.
Nevertheless, stock’s Earnings Per Share (EPS) this year is 50.70%. This publicly-traded company’s shares outstanding now amounts to $27.37 million, simultaneously with a float of $25.69 million. The organization now has a market capitalization sitting at $827.91 million. At the time of writing, stock’s 50-day Moving Average stood at $28.49, while the 200-day Moving Average is $24.96.
TransMedics Group Inc. (TMDX) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Medical Devices Industry. TransMedics Group Inc.’s current insider ownership accounts for 1.70%, in contrast to 69.80% institutional ownership. According to the most recent insider trade that took place on Jul 15, this organization’s Chief Financial Officer sold 10,000 shares at the rate of 35.00, making the entire transaction reach 350,000 in total value, affecting insider ownership by 5,714. Preceding that transaction, on Jul 15, Company’s Chief Commercial Officer sold 5,152 for 35.10, making the whole transaction’s value amount to 180,835. This particular insider is now the holder of 46,076 in total.
TransMedics Group Inc. (TMDX) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 3/30/2021, the organization reported -$0.29 earnings per share (EPS) for the three months, surpassing the consensus estimate (set at -$0.29) by $0. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.26 per share during the current fiscal year.
TransMedics Group Inc.’s EPS increase for this current 12-month fiscal period is 50.70% and is forecasted to reach -0.57 in the upcoming year.
TransMedics Group Inc. (NASDAQ: TMDX) Trading Performance Indicators
Let’s observe the current performance indicators for TransMedics Group Inc. (TMDX). It’s Quick Ratio in the last reported quarter now stands at 10.90. The Stock has managed to achieve an average true range (ATR) of 2.41. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 32.85.
In the same vein, TMDX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.07, a figure that is expected to reach -0.28 in the next quarter, and analysts are predicting that it will be -0.57 at the market close of one year from today.
Technical Analysis of TransMedics Group Inc. (TMDX)
If we take a close look at the recent performances of TransMedics Group Inc. (NASDAQ: TMDX), its last 5-days Average volume was 0.36 million that shows plunge from its year to date volume of 0.62 million. During the previous 9 days, stock’s Stochastic %D was recorded 44.17% While, its Average True Range was 2.55.
Raw Stochastic average of TransMedics Group Inc. (TMDX) in the period of the previous 100 days is set at 30.66%, which indicates a major fall in contrast to 36.38% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 80.22% that was higher than 77.58% volatility it exhibited in the past 100-days period.